iReadMore

Word Reading Therapy

Free · In-App Purchases · Designed for iPad. Not verified for macOS.

iReadMore is a new reading therapy for improving single word reading ability. It is for people with an acquired reading disorder (alexia) or aphasia due to a stroke, brain injury or dementia. Start your 7 day free trial now! iReadMore Features: Adaptive Algorithm - iReadMore adapts to your abilities, keeping the therapy relevant and challenging. Self-led Therapy - iReadMore allows you to be in control of your own therapy with unlimited access. Science-Driven and Clinically-Proven Results - All of our therapies are developed through years of dedicated research at University College London by a team of scientists and clinicians. Integrated Feedback - Complete reading tests and see your own progress. iReadMore Research Summary: - iReadMore therapy has been tested in two clinical trials. It was shown to improve reading ability in people with pure alexia (Woodhead et al., 2013) and central alexia (Woodhead et al., 2018) - In the clinical trial of iReadMore for central alexia (the most common form of acquired reading disorder), the average improvement in reading accuracy was 8.7% for trained words. Three months after finishing the therapy, users still had significantly better reading ability than before they started. - Anonymised results from the app will be collected to test how effective the app is and to improve our understanding of reading rehabilitation. For more information and help getting started with iReadMore, please visit: https://www.ucl.ac.uk/icn/research/research-groups/neurotherapeutics/therapy-apps/ireadmore-app If you have any other questions, please email us at ireadmore@ucl.ac.uk iReadMore is a Class I CE marked medical device.

  • This app has not received enough ratings or reviews to display an overview.

Security update

The developer, Alex Leff, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .

  • Data Not Linked to You

    The following data may be collected but it is not linked to your identity:

    • Identifiers

Privacy practices may vary based, for example, on the features you use or your age. Learn More

The developer has not yet indicated which accessibility features this app supports. Learn More

Size
1 GB
Category
Medical
Compatibility
Requires iOS 12.0 or later.
  • iPhone
    Requires iOS 12.0 or later.
  • iPad
    Requires iPadOS 12.0 or later.
  • iPod touch
    Requires iOS 12.0 or later.
  • Mac
    Requires macOS 11.0 or later and a Mac with Apple M1 chip or later.
  • Apple Vision
    Requires visionOS 1.0 or later.
Languages
English
Age Rating
4+
In-App Purchases
Yes
  • iReadMore Access - 6 Months 29,99 €
  • iReadMore Access - 3 Months 17,99 €
  • iReadMore Access - 1 Month 5,99 €
Provider
NEUROSPEECHAI LTD
  • NEUROSPEECHAI LTD has identified itself as a trader for this app and confirmed that this product or service complies with European Union law.
  • DUNS Number
    230549312
  • Address
    168 Church Road
    HOVE
    N/A
    BN3 2DL
    United Kingdom
  • Phone Number
    +44 7812080759
  • Email
    a.leff@ucl.ac.uk
Copyright
© Prof Alex Leff